AU5669694A - Antagonists of human gamma interferon - Google Patents

Antagonists of human gamma interferon

Info

Publication number
AU5669694A
AU5669694A AU56696/94A AU5669694A AU5669694A AU 5669694 A AU5669694 A AU 5669694A AU 56696/94 A AU56696/94 A AU 56696/94A AU 5669694 A AU5669694 A AU 5669694A AU 5669694 A AU5669694 A AU 5669694A
Authority
AU
Australia
Prior art keywords
antagonists
gamma interferon
human gamma
human
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56696/94A
Other languages
English (en)
Inventor
Gail F. Seelig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU5669694A publication Critical patent/AU5669694A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU56696/94A 1992-11-20 1993-11-19 Antagonists of human gamma interferon Abandoned AU5669694A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98052792A 1992-11-20 1992-11-20
US980527 1992-11-20
PCT/US1993/011110 WO1994012531A1 (fr) 1992-11-20 1993-11-19 Antagonistes de l'interferon gamma humain

Publications (1)

Publication Number Publication Date
AU5669694A true AU5669694A (en) 1994-06-22

Family

ID=25527631

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56696/94A Abandoned AU5669694A (en) 1992-11-20 1993-11-19 Antagonists of human gamma interferon

Country Status (6)

Country Link
EP (1) EP0668873A1 (fr)
JP (1) JPH07508763A (fr)
AU (1) AU5669694A (fr)
CA (1) CA2149785A1 (fr)
EE (1) EE9400365A (fr)
WO (1) WO1994012531A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
EP2336179A1 (fr) * 2002-11-08 2011-06-22 Ablynx N.V. Anticorps a domaine unique stabilises
US20060034845A1 (en) 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
BG66458B1 (bg) * 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625866B2 (en) * 1989-04-19 1992-07-16 F. Hoffmann-La Roche Ag Soluble interferon-gamma receptors and methods for their production
IL91562A0 (en) * 1989-09-07 1990-04-29 Yeda Res & Dev Interferon-gamma receptor fragment and its production
CA2081309A1 (fr) * 1990-04-24 1991-10-25 Paul J. Zavodny Recepteurs solubles tronques du gamma-interferon
DE69115917T2 (de) * 1990-09-27 1996-05-23 Schering Corp Humane gammainterferonantagonisten

Also Published As

Publication number Publication date
EE9400365A (et) 1996-04-15
EP0668873A1 (fr) 1995-08-30
CA2149785A1 (fr) 1994-06-09
JPH07508763A (ja) 1995-09-28
WO1994012531A1 (fr) 1994-06-09

Similar Documents

Publication Publication Date Title
AU5010793A (en) Human interleukin-13
AU4873193A (en) Use of substituted benzimidazoles
ZA936097B (en) Human interleukin-13
GB2255503B (en) Improved use of ß2-bronchodilator drugs
AU569365B2 (en) Stabilization of human gamma interferon
IL106553A0 (en) Substituted imidazoles and pharmaceutical compositions containing them
AU118073S (en) Set of utensils
AU1962988A (en) Stabilized formulations of gamma interferons
AU2724588A (en) Gamma interferon formulation
AU626005B1 (en) Treatment of endometriosis
AU3864089A (en) Nonglycosylated human interleukin-3 compositions
AU6643690A (en) Polypeptide inhibitors of gamma interferon
HU9202394D0 (en) Derivatives of cyclohexane and tetrahydro-pyrane
AU5669694A (en) Antagonists of human gamma interferon
AU5737494A (en) Human thrombospondin-4
GB9317103D0 (en) Derivatives of virginiamycin m1
ZA932553B (en) New use of B-carbolines
AU5371694A (en) Use of the tarchonanthus camphoratus
GB9414923D0 (en) Preparation of electrode
AU3422393A (en) Novel RXR-containing heterodimers and method of use
AU3404293A (en) Novel substituted stannosilicates and preparation thereof
ZA944577B (en) Preparation of aminopropionitriles
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
GB9109186D0 (en) Preparation of thionucleosides
KR950000006Y1 (en) Fastenings of sport-shoes